BioLife Solutions, Inc. Forecast, price target & analysts
BioLife Solutions, Inc. Target price 2026 - Analyst rating & recommendation
BioLife Solutions, Inc. Classifications & Recommendation
BioLife Solutions, Inc. Price Target
| Target Price | $31.62 |
| Price | $37.30 |
| Deviation |
15.23%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target BioLife Solutions, Inc. 2027 .
The average BioLife Solutions, Inc. target price is $31.62.
This is
15.23%
register free of charge
$34.65
7.10%
register free of charge
$31.31
16.06%
register free of charge
|
|
| A rating was issued by 15 analysts: 7 Analysts recommend BioLife Solutions, Inc. to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioLife Solutions, Inc. stock has an average upside potential 2027 of
15.23%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 96.21 | 116.84 |
| 28.88% | 21.44% | |
| EBITDA Margin | -0.85% | 25.97% |
| 84.89% | 3,147.04% | |
| Net Margin | -4.78% | 26.39% |
| 82.31% | 651.95% |
11 Analysts have issued a sales forecast BioLife Solutions, Inc. 2026 . The average BioLife Solutions, Inc. sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an BioLife Solutions, Inc. EBITDA forecast 2026. The average BioLife Solutions, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 BioLife Solutions, Inc. Analysts have issued a net profit forecast 2026. The average BioLife Solutions, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.09 | 0.63 |
| 79.07% | 800.00% | |
| P/E | 59.14 | |
| EV/Sales | 14.91 |
11 Analysts have issued a BioLife Solutions, Inc. forecast for earnings per share. The average BioLife Solutions, Inc. EPS is
This results in the following potential growth metrics and future valuations:
BioLife Solutions, Inc....
Current BioLife Solutions, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Benchmark |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Jul 27 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| Jefferies |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| Lake Street |
Locked
➜
Locked
|
Locked | Jul 22 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 22 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Benchmark:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Jul 27 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Jul 22 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 22 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 29 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
